REG - Clean Power Hydrogen - Appointment of Joint Broker

Clean Power HydrogenAnnouncement

29/01/2026 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260129:nRSc8000Qa&default-theme=true

RNS Number : 8000Q  Clean Power Hydrogen PLC  29 January 2026

The information communicated within this announcement is deemed to constitute
inside information as stipulated under the Market Abuse Regulations (EU) No.
596/2014 which is part of UK law by virtue of the European
Union (withdrawal) Act 2018. Upon the publication of this announcement, this
inside information is now considered to be in the public domain.

 

 

29 January 2026

Clean Power Hydrogen plc

("CPH2" or the "Company")

 

Appointment of Joint Broker

 

CPH2 (LSE:CPH2), which has developed market disrupting and IP-protected
Membrane-Free Electrolyser ("MFE") technology for the production of commercial
high purity hydrogen and medical-grade oxygen, announces that it has appointed
Turner Pope Investments (TPI) Limited ("Turner Pope") as Joint Broker to the
Company.

 

Commenting, Chief Executive Officer of CPH2, Jon Duffy, said: "We are pleased
to add the expertise of Turner Pope to our broking team which will support our
strategy to strengthen both our communications with the Stock Market and the
marketability of our shares."

 

Enquiries:

 

Clean Power Hydrogen
plc
    via Square1 Consulting

Jon Duffy, Chief Executive Officer

James Hobson, Chief Financial Officer

 

Cavendish Capital Markets Limited - NOMAD & Joint Broker

Neil McDonald
 
   +44 131 220 9771

Peter Lynch
 
     +44 131 220 9772

 

Turner Pope Investments (TPI) Limited - Joint Broker

Andy Thacker/Guy McDougall
                                       +44 203 657 3657

 

 

Square1 Consulting Limited
                                         +44 7831 381201

David
Bick

 

Background on CPH2

CPH2 is the holding company of Clean Power Hydrogen Group Limited which has a
decade of dedicated research and product development experience. This
experience has resulted in the creation and proving of simple, safe and
sustainable technology which is designed to deliver a modular solution to the
hydrogen production market in a cost-effective, scalable, reliable and
long-lasting manner. The Group's strategic objective is to deliver the lowest
Levelised Cost of Hydrogen ("LCOH") in the market in relation to the
production of green hydrogen. CPH2 is listed on the AIM market and trades
under the ticker LSE: CPH2.

 

For more information: https://www.cph2.com (https://www.cph2.com/)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  APPFZGZMNRZGVZM



            Copyright 2019 Regulatory News Service, all rights reserved